|
[1]SUN YM, ZHOU JL, WANG L, et al.New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J].Hepatology, 2017, 65 (5) :1438-1450.
|
|
[2]WANLESS IR, NAKASHIMA E, SHERMAN M.Regression of human cirrhosis.Morphologic features and the genesis of incomplete septal cirrhosis[J].Arch Pathol Lab Med, 2000, 124 (11) :1599-1607.
|
|
[3]BEDOSSA P, POYNARD T, French METAVIR Cooperative Study Group.An algorithm for the grading of activity in chronic hepatitis C[J].Hepatology, 1996, 24 (2) :289-293.
|
|
[4]ISHAK KG, BAPTISTA A, BIANCHI L, et al.Histological grading and staging of chronic hepatitis[J].J Hepatol, 1995, 22 (6) :696-699.
|
|
[5]MARCELLIN P, GANE E, BUTI M, et al.Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B:A 5-year open-label follow-up study[J].Lancet, 2013, 381 (9865) :468-475.
|
|
[6]TSOCHATZIS E, BRUNO S, ISGRO G, et al.Collagen proportionate area is superior to other histological methods for subclassifying cirrhosis and determining prognosis[J].J Hepatol, 2014, 60 (5) :948-954.
|
|
[7]XU S, WANG Y, TAI DCS, et al.qFibrosis:A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J].J Hepatol, 2014, 61 (2) :260-269.
|
|
[8]NAGULA S, JAIN D, GROSZMANN RJ, et al.Histologicalhemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis[J].J Hepatol, 2006, 44 (1) :111-117.
|
|
[9]SETHASINE S, JAIN D, GROSZMANN RJ, et al.Quantitative histological-hemodynamic correlations in cirrhosis[J].Hepatology, 2012, 55 (4) :1146-1153.
|
|
[10]ZIPPRECH A, GARCIA-TSAO G, ROGOWSKI S, et al.Prognostic indicators of survival in patients with compensated and decompensated cirrhosis[J].Liver Int, 2012, 32 (9) :1407-1414.
|
|
[11]RIPOLL C, BANARES R, RINCON D, et al.Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era[J].Hepatology, 2005, 42 (4) :793-801.
|
|
[12]KIM MY, CHO MY, BAIK SK, et al.Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension[J].J Hepatol, 2011, 55 (5) :1004-1009.
|
|
[13]KIM SU, OH HJ, WANLESS IR, et al.The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis[J].J Hepatol, 2012, 57 (3) :556-563
|
|
[14]CHON YE, PARK JY, MYOUNG SM, et al.Improvement of liver fibrosis after long-term antiviral therapy assessed by fibroscan in chronic hepatitis B patients with advanced fibrosis[J].Am J Gastroenterol, 2017, 112 (6) :882-891.
|
|
[15]LIANG X, XIE Q, TAN D, et al.Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy:A 2-year prospective study[J].J Viral Hepat, 2018, 25 (3) :296-305.
|
|
[16]DONG XQ, ZHAO W, LI J, et al.Declining in liver stiffness can not indicate fibrosis regression in patients with chronic hepatitis B:A 78-week prospective study[J].J Gastroenterol Hepatol, 2019, 34 (4) :755-763..
|
|
[17]KIM WR, BERG T, ASSELAH T, et al.Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients[J].J Hepatol, 2016, 64 (4) :773-780.
|
|
[18]KONG YY, SUN YM, ZHOU JL, et al.Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir[J].J Viral Hepat, 2019.[Epub ahead of print]
|
|
[19]HE ZY, WANG BQ, YOU H.Clinical application of quantitative assessment of liver fibrosis based on pathology and imaging technology[J].J Clin Hepatol, 2018, 35 (1) :20-23. (in Chinese) 何志颖, 王冰琼, 尤红.基于病理和影像学的肝纤维化量化评估技术的临床应用[J].临床肝胆病杂志, 2018, 35 (1) :20-23.
|
|
[20]WANG B, SUN Y, ZHOU J, et al.Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients[J].Mod Pathol, 2018, 31 (10) :1567-1577.
|
|
[21]BEDOSSA P.Reversibility of hepatitis B virus cirrhosis after therapy:who and why?[J].Liver Int, 2015, 35 (Suppl 1) :78-81.
|
|
[22]STUECK AE, WANLESS IR.Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis[J].Hepatology, 2015, 61 (5) :1696-1707.
|
|
[23]DEZS K, ROKUSZ A, BUGYIK E, et al.Human liver regeneration in advanced cirrhosis is organized by the portal tree[J].JHepatol, 2017, 66 (4) :778-786.
|
|
[24]XUAN RJ, ZHAO XY, HU DD, et al.Three-dimensional visualization of the microvasculature of bile duct ligation-induced liver fibrosis in rats by X-ray phase-contrast imaging computed tomography[J].Sci Rep, 2015, 5:11500.
|
|
[25]QIN LL, ZHAO XY, JIAN JB, et al.High-resolution 3D visualization of ductular proliferation of bile duct ligation-induced liver fibrosis in rats using X-ray phase contrast computed tomography[J].Sci Rep, 2017, 7 (1) :4215.
|
|
[26]ENOMOTO M, IKURA Y, TAMORI A, et al.Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C[J].United European Gastroenterol J, 2018, 6 (9) :1391-1400.
|
|
[27]D'AMBROSIO R, AGHEMO A, RUMI MG, et al.A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis[J].Hepatology, 2012, 56 (2) :532-543.
|
|
[28]BEDOSSA P.Pathology of non-alcoholic fatty liver disease[J].Liver Int, 2017, 37 (Suppl 1) :85-89.
|
DownLoad: